Background: Aberrant hypermethylation of tumour suppressor genes (TSGs) occurring in hepatocellular carcinoma (HCC) could provide a mean of molecular characterisation of this cancer. The aim of this study was to investigate promoter methylation and gene expression of selected TSGs in HCC to identify candidate genes for further validation as potential biomarkers.
Methods: Methylation-specific multiplex ligation-dependent probe amplification method was used to measure the methylation status of 25 TSGs in 49 HCC samples and 36 corresponding non-cancerous liver tissue samples. Relative expression of the differentially methylated genes was assessed at the mRNA level using quantitative PCR.
Results: We observed a significantly higher methylation in genes WT1, PAX5, PAX6, PYCARD and GATA5 in HCC compared with control samples. The expression of PAX5 was significantly decreased by methylation; conversely methylation of WT1 was associated with higher mRNA levels. Methylation of GATA5 was significantly associated with overall survival and methylation of WT1 and PAX5 significantly varied between patients with ALBI score 1 vs. 2+3. Moreover, PAX5 was significantly more methylated in patients with tumour grade 2+3 vs. grade 1, and methylation of the PAX5 correlated with the patient's age at the time of diagnosis.
Conclusions: HCC evince aberrant promoter methylation of WT1, PAX5, PAX6, PYCARD and GATA5 genes. Correlation between GATA5, WT1 and PAX5 methylation and clinical/histological parameters is suggestive of applicability of these markers in non-invasive (epi)genetic testing in HCC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1515/cclm-2015-1198 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Giant ovarian solid and cystic masses mixed with three types of tumors: A rare case report and literature review.
Heliyon
August 2024
Institute of Pathology, China Three Gorges University, Yichang, China.
Background: Most ovarian tumors exhibit a pure histological characteristic. Nevertheless, a combination of tumors with the same histogenetic origin but different histologic subtypes is relatively common. Additionally, co-occurrence of tumors with different histogenetic origins is very rare.
View Article and Find Full Text PDFEpithelioid inflammatory myofibroblastic sarcoma: a pitfall in the differential diagnosis of ALK-positive anaplastic large cell lymphoma.
J Hematop
June 2023
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
An 18-year-old female presented with a 4.5 cm abdominal mass. Biopsy showed sheet-like growth of large tumor cells with round to oval nuclei, 1-2 nucleoli, and abundant cytoplasm.
View Article and Find Full Text PDFDNA hypermethylation of , and genes in oropharyngeal cancer associated with human papillomavirus.
Epigenetics
November 2022
Department of Clinical Biochemistry and Diagnostics, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Czech Republic.
Recently, an increasing incidence of HPV-induced oropharyngeal squamous cell carcinoma (OPSCC) has been observed. Moreover, locoregionally advanced stages require a combined modal approach, and the prognosis is poor. Therefore, it is essential to find early diagnostic and prognostic biomarkers.
View Article and Find Full Text PDF[Rhabdomyosarcomas: structural distribution and analysis of an immunohistochemical profile].
Arkh Patol
November 2020
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia.
Unlabelled: Rhabdomyosarcoma (RMS) is a malignant soft tissue tumor originating from primitive mesenchymal cells, which is most common in children.
Objective: To qualitatively and quantitatively assess the expression of myogenic transcription factors on a large sample, to identify potential phenotypic differences, and to estimate the distribution and frequency of aberrant markers, such as ALK, PAX5, WT1, PCK, CAM5.2, SIX1, and Synaptophysin.
Methylation patterns in dysplasia in inflammatory bowel disease patients.
Scand J Gastroenterol
June 2020
Portuguese Inflammatory Bowel Diseases Study Group, Porto, Portugal.
Article Synopsis
- IBD with colonic involvement is linked to a higher risk of colorectal cancer, but distinguishing between cancer related to IBD and sporadic instances is challenging.
- Data suggests that abnormal DNA methylation may play a key role in the development of cancer in IBD patients.
- A study involving patients with various types of dysplasia and cancer assessed methylation patterns in the colonic mucosa, finding significant links between certain gene methylations and IBD along with dysplastic lesions, highlighting the potential for future classifications based on these patterns.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!